arrow
S

Simon P. Hart

University of Hull
H指数:37
被引数:4,902

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparing the effectiveness, cost-effectiveness and implementation of low-dose oral modified release morphine in people with chronic breathlessness: a synopsis of a RCT and process evaluation

比较低剂量口服缓释吗啡在慢性呼吸困难患者中的疗效、成本效益及实施情况:一项随机对照试验和过程评估的概要

2026-05-010
PRE
Morphine for chronic breathlessness (MABEL) in the UK: a multi-site, parallel-group, dose titration, double-blind, randomised, placebo-controlled trial

英国慢性呼吸困难 Morphine 治疗(MABEL)研究:一项多中心、平行组、剂量滴定、双盲、随机、安慰剂对照试验

2025-09-280
OAAI
Mirtazapine to alleviate severe breathlessness in patients with COPD or ILD: an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trial (BETTER-B).
2024-10-300
PRE
Mirtazapineto alleviate severe breathlessness in patients with COPD or interstitial lung diseases (BETTER-B): an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trial

Mirtazapineto缓解COPD或间质性肺病患者的严重呼吸困难 (更好-B): 一项国际,多中心,双盲,随机,安慰剂对照,3期混合方法试验

2024-10-011
OAAI
Real-world data from 24 UK centres for the use of nintedanib for progressive fibrosing interstitial lung disease
2023-10-270
PRE
PCSK6 and Survival in Idiopathic Pulmonary Fibrosis
2023-06-0115
OAAI